Brief news reports on Tuberculosis

Relatively low primary drug resistant tuberculosis in southwestern Ethiopia

Abstract (provisional)


The prevalence of drug resistant tuberculosis (TB) in Ethiopia in general, and Jimma area in particular, is not well documented. We conducted a study at Jimma University specialized hospital in southwest Ethiopia among new cases of smear positive TB patients to determine the pattern of resistance to first-line drugs.

Read More →

India: TB declared a notifiable disease - what does this mean for people living with HIV, diagnosed with TB

A study published just before Christmas in the Clinical Infectious Diseases Journal on "totally-drug-resistant-tuberculosis" in India led to several news reports on multidrug-resistant TB (MDR-TB) but also extensively drug-resistant tuberculosis (XDR-TB) in different states. The government in response has decided to enforce an old public health law under which TB is a notifiable disease.

Read More →

Breathalyzers to test tuberculosis and stamped leaves to detect disease in plants

SEATTLE -- The Bill & Melinda Gates Foundation, through its Grand Challenges Explorations initiative, today announced over 100 new grants of US$100,000 each to support innovative global health and development proposals that have the potential to unlock transformative, life-saving solutions in the developing world. Additionally, the Gates Foundation announced additional funding of up to US$1 million each for six existing Grand Challenges Explorations projects to enable grantees to continue to advance their ideas towards global impact.

Read More →

Aeras and IDRI sign agreement to jointly develop novel tuberculosis vaccine

Rockville, MD & Seattle, WA, USA (May 9, 2012) – Aeras and the Infectious Disease Research Institute (IDRI) announce today a new agreement to conduct joint development activities with respect to IDRI’s novel tuberculosis vaccine candidate. This collaboration reflects the missions of the two non-profit product development partnerships to use cutting-edge science to develop products that address critical diseases of underserved populations around the world, including tuberculosis.

Read More →

USAID launches five-year initiative in Nigeria to strengthen HIV, TB services

U.S. Ambassador to Nigeria Terence McCulley on Tuesday in Abuja, Nigeria, launched a five-year, $224 million USAID program, titled Strengthening Integrated Delivery of HIV/AIDS Services (SIDHAS), that aims to "increas[e] access to high-quality comprehensive HIV/AIDS and tuberculosis prevention, treatment, care and related services through improved efficiencies in service delivery," the Daily Trust reports (Odeyemi/Odafor, 5/8). 

Read More →

Global Fund announces $1.6B in additional funding for 2012-2014

The Global Fund to Fight AIDS, Tuberculosis and Malaria "expects to have an additional $1.6 billion to fund projects in 2012-2014, [the fund's General Manager Gabriel Jaramillo] said on Wednesday, a turnaround from a funding freeze last year," Reuters reports (Miles, 5/9). "The new funds are a result of 'strategic decisions made by the Board, freeing up funds that can be invested in countries where there is the most pressing demand,' a statement by the fund said," according to PlusNews (5/10). "The money includes funds from new donors, from traditional donors who are advancing their payments or increasing contributions and from some donors, such as China, that have offered to support projects in their own country to free up cash for more pressing needs elsewhere, Jaramillo said," Reuters notes (5/9). "This forecast is better than expected, and it comes from the fantastic response we are getting to our transformation," Jaramillo said, adding, "But we need more to get the job done. Countries that implement our grants are saving more and more people, but demand for services is still enormous," according to the statement (5/9).

Read More →

Xpert TB test very cost-effective in South Africans starting ART

Two Xpert Mycobacterium tuberculosis rifabutin resistance assays in South Africans starting antiretroviral therapy (ART) would be highly cost-effective, according to a cost-benefit modeling analysis using a hypothetical South African population.

Read More →

NAM: HATIP newsletter 2012

HIV & AIDS treatment in practice (HATIP) is a regular email newsletter for healthcare workers and community-based organisations on HIV treatment in resource-limited settings.

Read More →

Improving African justice systems essential to prevent spread of HIV and TB in prisons

In order to reduce HIV and TB in African prisons, African governments and international health donors should fund criminal justice reforms, experts from Human Rights Watch say in this week's PLoS Medicine.

Read More →

Key advocates set agenda for building network of TB-affected community reps

4 May 2012 – Geneva - Thirty advocates from a dozen countries gathered in Geneva this week. There were a number of familiar personalities – women and men who have been raising their voices on behalf of TB-affected communities for years. But there were also several fresh faces – community activists devoted to the cause of HIV who were new to TB advocacy.

Read More →

Page 626 of 685 · Total posts: 10

←First 625 626 627 Last→